Page results
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
Today, this National Day of Reflection, we remember those members of staff who we sadly lost due to COVID-19.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
Please be advised that from 1 October 2021, the management of the Queen Square private consulting rooms (PCR) will be transferring from Queen Square Enterprises to UCLH Private Healthcare. This means that both private inpatient and outpatient facilities at the National Hospital for Neurology and Neurosurgery (NHNN) will now be managed by the private arm of UCLH NHS Foundation Trust.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
File results
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0597 - Urothelial cancer treatments
-
FOI/2024/0605 - Finance software system/ installation and expiry of software
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0609 - Healthcare Associated Infections (HAIs) cases
-
FOI/2024/0615 - Electronic Patient Record (EPR) software spend/ Trust Integration Engine (TIE)
-
FOI/2024/0612 - Orthotic and prosthetic services at the Trust
-
FOI/2024/0616 - Never events involving Medical Associate Professionals (MAPs) from 2021/22-2023/24